Clinical Trial Update: Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the drug-drug interaction between cladribine and pantoprazole in multiple sclerosis subjects has completed. Results were posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• MAVENCLAD (cladribine)
• Protonix (pantoprazole)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED | Results posted: 2015-10-20